Search

Editors

Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Elizabeth K. Spahn Editor Emeritus

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor


FCPA Blog Daily News

Entries in GlaxoSmithKline (35)

Wednesday
Nov022016

NYT Report: GSK ignored whistleblower who reported China fraud and bribery

A report by David Barboza of the New York Times details how an apparently highly-placed whistleblower in GlaxoSmithKline's China operation sent the head office in London a series of long, well-written memos about illegal sales practices that directors, executives, and auditors chose to ignore.

Click to read more ...

Friday
Sep302016

GSK pays SEC $20 million to settle China FCPA violations

The Securities and Exchange Commission said Friday UK-based pharma GlaxoSmithKline plc will pay a $20 million civil penalty to settle charges that it violated the Foreign Corrupt Practices Act when China-based subsidiaries spent millions of dollars on pay-to-prescribe schemes for several years to pump up sales.

Click to read more ...

Thursday
Jan212016

DOJ indicts China scientists for alleged GSK trade secrets ripoff

The U.S. Attorney’s Office for the Eastern District of Pennsylvania filed an indictment Wednesday charging five people in an alleged scheme to steal trade secrets from pharma giant GlaxoSmithKline. 

Click to read more ...

Monday
Jun222015

Alison Taylor: Does competition cause corruption?

You might expect corrupt companies to downplay and devalue the principles of market competition. In fact the opposite is true.

Click to read more ...

Monday
Jun152015

Peter Humphrey and wife released from prison

British investigator Peter Humphrey and his American wife Yu Yingzeng have been released early from prison in China.

Click to read more ...

Thursday
May282015

Pharma news: China restricts hospital drug sales 

China is pushing reforms at public hospitals in the wake of widespread complaints about inadequate healthcare services and corruption related to drug sales.

Click to read more ...

Thursday
Mar052015

Managing compliance in China's emerging new civilization

President Xi Jinping visits UNESCO in Paris in 2014A new phase has begun in the maturation of China as an economic superpower, an era that President Xi Jinping has taken to calling “the new normal.” The ongoing challenge for Beijing is to transition from a largely investment-propelled, export-oriented economy to one increasingly driven by consumption.

Click to read more ...

Monday
Feb232015

Here's proof the era of global enforcement is upon us

Let's go straight to some news from beyond America's shores during the past year.

Click to read more ...

Tuesday
Feb102015

Qualcomm pays $975 million to resolve China antitrust offenses 

Image courtesy of QualcommQualcomm Inc. agreed to pay a fine of $975 million to regulators in China. The biggest corporate fine in the country's history resolves a 14-month investigation for anti-competitive practices.

Click to read more ...

Tuesday
Oct282014

Collective Action: A new approach to combat corruption (Part 7)

In my prior post on Collective Action, I wrote about the importance of voluntary codes of conduct and concluded that in an era of weak regulation, corporate behaviour would have been significantly worse over the last decades without them.

Click to read more ...

Tuesday
Oct212014

China state newspaper accuses foreign firms of tax evasion

China’s state-run newspaper People’s Daily has accused multinational companies of avoiding taxes in China and urged authorities to take measures to combat tax evasion.

Click to read more ...

Thursday
Oct162014

Novartis employee pleads guilty in Poland bribe case

An executive at Swiss pharma Novartis pleaded guilty in a bribery prosecution in Poland, the company has confirmed.

Click to read more ...